A sector that's even better than insurance...

A sector that's even better than insurance... Three of our most valuable secrets – capital-efficient stocks, how to find them, when to buy them... Why we avoid life-insurance stocks...
As most of you know, Sean Goldsmith is on vacation for this week and next, so I (Porter Stansberry) have pledged to write nine 'Friday' Digests in a row.
These are the if-our-roles-were-reversed essays I write, trying to tell you the most important things I've learned. If you haven't seen them yet, check out my first two efforts here and here. By the way, my staff doubts my ability to deliver something both unique and truly valuable over each of the remaining seven Digests. Follow along to see if I can, in fact, deliver what I've promised. You be the judge. And remember: there is no such thing as teaching... there is only learning.
Yesterday, I told you that there were three particular sectors of the stock market that give outside passive investors the easiest and safest opportunities over the long term. Pro baseball Hall of Famer Ted Williams didn't bat .406 in 1941 by swinging at every pitch.
He carefully broke the strike zone down and decided to only swing at pitches that were in his favorite spots – his own personal strike zone. He knew he had a much better chance of hitting those pitches than the pitchers had of throwing it into the few places where he wouldn't swing. Ted Williams only struck out 27 times that season.
The more time I spend in the financial markets, the more convinced I become that most investors should only buy stocks in these few "sweet spots." In these areas, outside investors have the tools to decide whether or not a stock is in the strike zone. If you can learn to limit yourself to only making capital commitments in these areas – your personal "strike zone" – I'm certain you can vastly improve your results.
Yesterday, for example, I showed you why specific types of insurance companies (those with disciplined underwriting) almost always outperform the market. Today, I'm going to show you why, as good as insurance stocks can be, they're not where you'll find the very best long-term results. No, for the very best long-term results, you should focus on what I call capital-efficient stocks. And, lucky for outside passive investors, there's one sector of the stock market that's both easy to understand and crowded with capital-efficient companies. Once you know the trick to identifying them, making a fortune in stocks is as easy as painting by numbers. Let me show you how.
Simple question: Do you think you could name any of the 20 best-performing stocks in the S&P 500 in the 50 years between 1957 and 2007? Wharton economist Jeremy Siegel wanted to answer this question thoroughly. It's not as easy to figure out as you might think, because the composition of the S&P 500 changes frequently. Siegel had to go back and get the actual list of stocks from 1957 and then follow each one, carefully, to see how much they paid out in dividends, spinoffs, mergers, and liquidations.
So... what were the real best-performing stocks over that 50-year period?
Company
Return
Philip Morris
19.8%
Abbott Labs
16.5%
Bristol-Myers
16.4%
Tootsie Roll
16.1%
Pfizer
16.0%
Coca-Cola
16.0%
Merck
15.9%
PepsiCo
15.5%
Colgate-Palmolive
15.2%
Crane
15.1%
H.J. Heinz
14.8%
Wrigley
14.7%
Fortune Brands
14.6%
Kroger
14.4%
Schering-Plough
14.4%
Procter & Gamble
14.3%
Hershey Foods
14.2%
Wyeth
14.0%
Royal Dutch Pet.
13.6%
General Mills
13.6%
Source: Jeremy Siegel, The Future For Investors
What I'm sure you can see for yourself is that, almost without exception, these companies sell high-margin products (some are extremely high-margin), in stable industries that are dominated by a handful of well-known brand names. Look at the top 10 names on the list – the ones that produced 15%-plus annual returns. My bet is that most of you have at least three or four of these companies' products in your house at all times. (Crane, by the way, is the obvious exception.)
What is it that Crane (a maker of high-margin industrial parts) has in common with these other companies? It's extraordinarily capital-efficient. Because of Crane's excellent, storied reputation (it has been in business since 1855), the unique, proprietary nature of its products, and the stable, long-term nature of its business, Crane doesn't have to spend a fortune on brand advertising or building new manufacturing plants to come up with new products every few years.
This means that as sales grow, the amount of capital that must be reinvested in the business doesn't grow much – or at all. Over the last 10 years, Crane has earned gross profits of nearly $8 billion and spent just $312 million on capital investments.
I learned the basic concepts behind capital efficiency by carefully studying the few large investments Warren Buffett made in the 1970s and 1980s. If you read his 1983 letter to shareholders, he basically gives the whole strategy away. But it's hidden... at the very end of the letter... underneath the headline: "Goodwill and its Amortization: The Rules and the Realities."
You can read Buffett's letter if you'd like... but I think you'll learn more about the practical application of this strategy if you'll go back and re-read my December 2007 Investment Advisory, where I recommended shares of Hershey. I've said many times, and in many places, that I believe my recommendation of Hershey will likely be the best stock pick I make in my entire career. I fully expect the investment to deliver 15% annual returns over the long term – the very long term. As I said when I recommended it, "the longer you hold this stock, the more rapidly your wealth will compound and you'll never have to sell – ever."
In my initial recommendation, I noted how capital efficient Hershey is...
Over the last 10 years, the company's annual capital spending has remained essentially unchanged. In 1997, the firm invested $172 million in additions to property and equipment. By the end of 2006, the annual capital budget had only increased to $198 million – a paltry 15%. Meanwhile, cash profits and dividends nearly doubled.
This is the beauty of capital-efficient businesses: As sales and profits grow, capital investments don't. Thus, the amount of money that's available to return to shareholders not only grows in nominal dollars, it also grows as a percentage of sales. In 1999, dividends paid out equaled 3.4% of sales. But by 2006, the company spent $735 million on dividends and share buybacks, an amount equal to 14.8% of sales.
Today, nearly seven years later, Hershey's sales have grown to more than $7 billion, but capital investments remain incredibly small – less than 5% of sales. Last year, with gross profits of more than $3 billion, Hershey distributed $550 million to shareholders. That's nearly 20% of gross profits and far more capital than it invested in its operations ($325 million).
That's another hallmark of capital-efficient companies: They almost always return more capital to shareholders each year than they spend in capital investments. Why doesn't Hershey distribute even more? It could... Cash flows from operations were more than $1 billion. But companies like Hershey will wait to buy back lots of stock (or make wise acquisitions) when prices are low. How can you do the same? How do you know when is the right time to buy these stocks, which almost always trade at rich premiums to the average S&P 500 stock?
You want to buy these stocks during the rare times they're cheap enough to safely take themselves private. Again, I explained the concept in my December 2007 issue...
Hershey's enterprise value is $11.5 billion. That's the amount of money it would require to pay off all of the company's debts and buy back all of the outstanding shares of stock at the current price.
The company earns more than $1 billion before taxes, interest, and depreciation. Its earnings are very consistent, and its brand places it in the upper tier of all businesses around the world. It could easily finance a bond offering large enough to buy itself – or "go private."
Thus, I think it is extremely unlikely that investors will lose money buying the stock at today's price... Given the company could easily finance the repurchase of all its stocks and bonds, I believe buying this stock is no more or less risky than buying its bonds.

That is the true definition of a "no risk" stock – an analysis of its cash flow shows it could afford to buy back both all of its debts and all of its shares... These situations are extremely attractive because, while you're only taking a risk that's similar to a bondholder, you're getting ownership of all of the company's future earnings.

You know when it's safe to buy these businesses by figuring out if they could finance a debt issuance in excess of their enterprise value. That can be a little tricky. So use a rule of thumb. These stocks are safe to buy (and likely to produce incredible long-term results) when you can buy them for around 10 years' worth of current cash flows from operations.
There's an easy way to keep your eye out for these world-class, long-term investments. We maintain a "Capital Efficiency Monitor" as part of our supplementary Stansberry Data service. We do all of the legwork (of course) and list the companies that are capital-efficient and whose shares are trading at a reasonable price (around 10 times cash flow).
You will also find businesses like these by looking in the portfolios of high-quality investors. I've noticed that Mario Gabelli's GAMCO team loves these kinds of businesses. Likewise, of course, the exchange-traded fund I mentioned on Tuesday – Meb Faber's Cambria Shareholder Yield Fund (SYLD) – is always going to feature a lot of these names, as companies have to be reasonably capital efficient and reasonably priced if they're going to rank in the top spots in terms of shareholder yield.
Here's another big helpful hint when it comes to this type of investing: It's critical to avoid companies who are returning huge amounts of capital to investors simply because their businesses have become obsolete. Companies like Western Union, for example, might look good on paper, but its future cash flows are seriously in jeopardy by new technologies.
If you're going to invest using this strategy, you want to stick to the very highest-quality businesses, whose products are timeless. I always ask myself this question: "Are my grandkids likely to want this brand and this product?" There's no brand or business in the world that will last forever, but you should try to focus on the stuff that's as close to forever as possible.
Here's another valuable tip. This is one of the few, genuine secrets to investing that I've ever learned. In fact, it's a little creepy. S&A Editor in Chief Brian Hunt first pointed it out to me: A lot of the companies that fit into our model of capital efficiency sell products that are highly addictive. Says Hunt...
If you look at the list of the 20 best-performing S&P 500 stocks during that time frame that kept their general corporate structure intact, you'll note many of them sold habit-forming products. It jumps right out at you. For example, Phillip Morris is at the top of the list. It was the top-performing S&P 500 stock from 1957 to 2007. It sold cigarettes, which contained addictive nicotine. Fortune Brands, which was called American Brands for a while, is on the list. It sold cigarettes and alcohol. Coca-Cola and PepsiCo are on the list. They sold soda, which is a sugar-delivery vehicle. Hershey Foods and Tootsie Roll are on the list. They sold chocolate and sugar. Wrigley is on the list. It sold sugary gum, like Big Red and Juicy Fruit. People love to get a little sugar rush. It's habit-forming.
Many drug companies are also on the list. These names include Abbott Labs, Bristol-Myers Squibb, Merck, Wyeth, Schering-Plough, and Pfizer. People get very, very accustomed to taking certain drugs. Much of the time, those drugs are useful, although sometimes they are not. I'm not saying they are good or bad, I'm simply pointing out that people get very accustomed – even addicted – to taking them.
You can make the case that some fast foods are addictive as well. Fast food is loaded with fat and sugar – stuff that makes people crave it. This is part of the reason McDonald's has been such a corporate success. McDonald's has returned an average of 13% a year for three decades, making investors extremely rich.
And the reason why it did so well is simple. When people form a habit around a product, it goes a long way toward ensuring repeat business. People get used to brands, and they grow resistant to switching. Also, when people get used to a product and the brand surrounding it, they are more likely to continue buying the product, even if the price increases a little.
Both of these help companies sustain sales growth and healthy profit margins. That's good for shareholders. It's also important to know that when these companies hit upon the right recipes or the right mix of whatever it takes to make good products, they don't have to make large, ongoing investments in the business. They don't have to spend tons of money on further research and development. Once Coca-Cola hit upon Coke, it didn't have to change it. The same goes for Budweiser, Hershey, and Tootsie Roll.

When you develop a product that people love and develop habits around, you don't tinker with it. You don't have to spend a lot of money on new research and development. You don't have to buy expensive, high-tech equipment. This means a larger percentage of revenues can be sent to shareholders – it's a capital-efficient business.

One more thing... I don't expect all (or even most) of the market's leaders from 1957 to 2007 to remain at the very top of the performance charts. But what I hope you'll notice is that the characteristics of the leading companies are the same. New brands come along and make small changes... and get very popular. New medicines are invented. New forms of addiction are marketed successfully. If you keep your eyes open, it's not all that hard to figure out which of these products and businesses are likely to do extremely well over the long term. Here's the list of the 10 best-performing stocks in the S&P 500 over the last 20 years (on an annualized basis):
Company
Return
Biogen
37.9%
Keurig
37.0%
Monster Beverage
36.9%
Gilead
33.3%
Celgene
32.6%
KC Southern
26.9%
Apple
25.7%
Ross
24.3%
Express Scripts
24.2%
Qualcomm
24.0%
Time Warner
23.4%
Regeneron
21.7%
Precision Cast
21.0%
O'Reilly Auto
20.7%
Autonation
20.5%
Tractor Supply
20.5%
Starbucks
20.4%
TJX
20.0%
Expeditors International
19.9%
The top five firms sell high-margin, branded drugs – as long as you agree that caffeine is a highly addictive drug. Likewise, although most people don't think about Starbucks as being a drug company, the company's decaf coffee contains more caffeine than McDonald's regular coffee does.
What is it really selling? Over the last 10 years, Starbucks has produced gross profits of $57 billion. It has only spent $7.3 billion on capital investments. It spent $5.5 billion buying back stock and another $1.7 billion on cash dividends. In short, even though it had to pay for a huge international build out, it has still been able to spend almost as much on its shareholders as it did on growing its business. That's pretty remarkable and an excellent indication that long-term shareholders in Starbucks will do very well...

New 52-week highs (as of 6/18/2014): Alcoa (AA), Apache (APA), Anadarko Petroleum (APC), Activision Blizzard (ATVI), Bank of Montreal (BMO), British Petroleum (BP), Chesapeake Energy (CHK), C&J Energy Services (CJES), Callon Petroleum (CPE), Carrizo Oil & Gas (CRZO), Chevron (CVX), WisdomTree Japan Small Cap Dividend Fund (DFJ), Discover Financial Services (DFS), ProShares Ultra Oil & Gas Fund (DIG), Dorchester Minerals (DMLP), Eni (E), First United Bancorp (FUBC), Cambria Foreign Shareholder Yield Fund (FYLD), iShares Dow Jones U.S. Insurance Fund (IAK), SPDR S&P International Health Care Fund (IRY), Coca-Cola (KO), Lorillard (LO), Medtronic (MDT), National Fuel Gas (NFG), PepsiCo (PEP), PowerShares Buyback Achievers Fund (PKW), PowerShares QQQ Fund (QQQ), ProShares Ultra Technology Fund (ROM), RPM International (RPM), Sabine Royalty Trust (SBR), Sanchez Energy (SN), Superior Energy Services (SPN), ProShares Ultra S&P 500 Fund (SSO), Constellation Brands (STZ), Cambria Shareholder Yield Fund (SYLD), Triangle Petroleum (TPLM), Targa Resources (TRGP), ProShares Ultra Utilities Fund (UPW), Walgreen (WAG), W.R. Berkley (WRB), and SPDR Utilities Select Sector Fund (XLU).
In the mailbag... a great question about life insurance versus property and casualty insurance. We still haven't gotten any real vitriol yet... Must be a bull market. Just wait until stocks drop 20% or so... then we'll see the haters come out. Like us or hate us. Just don't ignore us. Don't let your subscription expire without at least sending us something: feedback@stansberryresearch.com.
"The 6/18 Digest was excellent and I hope your readers appreciate the advice. I've been investing in insurance companies for a long time and completely agree that it is the best industry for investors. My biggest problem is the amount of research required. I love your monthly insurance data update. I would really like to see a newsletter that is totally focused on insurance. I would also like to see more data on insurance companies.
"I'm expanding my investment DD with your research. I used to simply look for insurance companies trading under book with a positive combined ratio and good management. I would buy under book and sell when it traded for 1.5x book. I will only hold the best of the best for long term. For example, I've held Markel for over 10 years and when it got hit in 2008, I bought as much as I could and considered the discount pricing a gift.
"By the way, I'm the founder and owner of a software company. About 5 years ago we decided to focus solely on developing software for insurance companies. I know you prefer the P&C space and I do as well for investing, but our experience and clients were in the offshore life insurance space so that is our focus. Business is great." – Paid-up Flex Alliance Subscriber
Porter comment: Great job buying Markel when you did. It's a very popular name in our office. And we specifically recommended buying shares during the crisis, noting that it was a great stock to hold for the long term.
"In yesterday's Digest (June 18), you listed 4 insurance companies with great underwriting discipline, and showed their stock price increases versus the S&P 500. I was impressed with the chart, and the investment results. I also noticed one more thing: these are all, apparently, property and casualty insurance firms. This seems counter-intuitive to me... how can an underwriting department set risks for unusual structures, or even events? (weddings? The World Cup? The Super Bowl?)
"The number of variables that must be considered seem astronomical, and the problems of pricing these risks seem even more monumental. I believe my question is this: from an investor's point of view, why is P&C insurance a much more lucrative business than life insurance? (There is only one variable to consider in pricing life insurance, right?) Thanks." – Paid-up subscriber Brian A.
Porter comment: Great question. The difficulty of underwriting niche property and casualty insurance is the whole game. The insurance companies that are able to develop the models and the thinking behind successful underwriting have a real market advantage. That's why we want to own them. On the other hand, there's no way to gain an advantage over other underwriters when it comes to life insurance. Everyone dies. No exceptions.
Regards,
Porter Stansberry
Baltimore, Maryland
June 19, 2014
The U.S. Treasury market is totally rigged...
S&A founder Porter Stansberry believes the market for U.S. Treasurys is "totally rigged."
In today's Digest Premium, he explains what he sees happening... and where the market may be headed next...
To subscribe to Digest Premium and receive today's analysis, click here.
The U.S. Treasury market is totally rigged...
Editor's note: In yesterday's Digest Premium, Stansberry & Associates founder Porter Stansberry explained why junk bonds are one of the most dangerous bubbles in the market right now. Today, he explains what's happening in the U.S. Treasury market... and where it may be headed...
The Federal Reserve has purchased around $3 trillion in U.S. Treasury bonds. We know that total outstanding U.S. obligations – Treasury bonds included – is around $10 trillion.
The total debt, of course, is much larger, at $17 trillion. But a lot of that paper is held by the Social Security Administration and other government agencies, which means a lot of it is tied up in other government-financing purposes.
Let's say that freely trading Treasurys are roughly $10 trillion. Well, the government owns 30% of it. That's a huge chunk of the market. That's why (and how) it's able to dictate bond prices.
A lot of the other paper is tied up by other central banks. Other central banks use U.S. Treasury bonds as their reserves, and some use Treasury bonds as their primary reserve.
Roughly 60% of the world economy's financial reserves are tied up in Treasury bonds. That means the dollar amount of bonds that are freely trading and available for purchase is relatively small, given the amount of money in the financial markets and in the currency markets.
Believe it or not, it is a possibility that we may see a run on Treasury bonds if there is any kind of tremor in the global economy.
We see that tremor shaping up in terms of volatility in emerging markets. It's kind of ironic. The fact is, the U.S. deficit is improving. This is mostly due to a decline in oil and energy imports and an increase in oil and energy exports. We are actually seeing dollar liquidity in emerging markets begin to fall. And as dollar liquidity falls, those emerging markets' central banks have to go out and buy U.S. Treasury bonds to support their own currencies. It's a strange situation. You're having a tilt in global liquidity actually coming to the dollar instead of going away from it.
As a result, we've seen a stronger dollar. We've seen much lower U.S. Treasury yields, and much higher U.S. Treasury bond prices. I don't see those trends reversing at any time in the near term, so I think we're going to continue to see lower rates in U.S. Treasury bonds.
The Federal Reserve is very lucky that we're having a massive oil boom. If we weren't, it would have become impossible for the Fed to reduce its buying from $85 billion a month down to $55 billion now. Its foreign central banks are increasing their Treasury bond purchases and replacing the Federal Reserve's buying campaign. That's lucky. Otherwise, the Fed would have had a very hard time extracting itself from the market.
What remains to be seen is what Treasury bond yields might do once the Fed actually begins to unwind its existing position. We don't know what its plans are to get rid of the $3 trillion in bonds that it owns, but it will be interesting to see how it extricates itself from that excess liquidity. Of course, at some point, it could fuel a large exit from bonds.
– Porter Stansberry
The U.S. Treasury market is totally rigged...
S&A founder Porter Stansberry believes the market for U.S. Treasurys is "totally rigged."
In today's Digest Premium, he explains what he sees happening... and where the market may be headed next...
To continue reading, scroll down or click here.
Back to Top